In summary, our findings demonstrate that BRAF inhibitors alone and in combination with the EGFR inhibitor cetuximab fail to induce extensive levels of apoptosis in BRAFV600E CRC cells. The gene discussed is EGFR; the disease is colorectal carcinoma.